1. Avoid cobicistat/elvitegravir-based regimens during pregnancy

   Correspondence 13 April 2019 Pages: 1 - 1

2. Belimumab: risk of depression, suicidal ideation

   News item 13 April 2019 Pages: 2 - 2

3. ISMP: new 2018 data on use of three psychoactive drugs

   News item 13 April 2019 Pages: 3 - 3

4. New Irish guide released for problem users of pregabalin

   News item 13 April 2019 Pages: 4 - 4

5. Singapore's HSA recalls contaminated losartan tablets

   News item 13 April 2019 Pages: 5 - 5

6. Vastly improved ADR reporting with new EV system

   News item 13 April 2019 Pages: 6 - 6

7. Dolutegravir, efavirenz: maternal & paediatric effects

   Clinical study 13 April 2019 Pages: 7 - 7

8. Immune checkpoint inhibitor toxicites from FAERS and OoSRs

   Clinical study 13 April 2019 Pages: 8 - 8

9. PPI or H2RA use not associated with fracture risk in young adults

   Clinical study 13 April 2019 Pages: 9 - 9

10. Risperidone: adverse events in paediatric patients

    Clinical study 13 April 2019 Pages: 10 - 10

11. Systematic review: haematologicial events with TKIs in CML

    Clinical study 13 April 2019 Pages: 11 - 11

12. Topical corticosteroid use increases risk of T2DM

    Clinical study 13 April 2019 Pages: 12 - 12

13. Abatacept

    Case report 13 April 2019 Pages: 13 - 13

14. Abatacept/adalimumab

    Case report 13 April 2019 Pages: 14 - 14

15. Abiraterone acetate

    Case report 13 April 2019 Pages: 15 - 15

16. Acetylcysteine

    Case report 13 April 2019 Pages: 16 - 16

17. Acetylcysteine/mecobalamin/methylfolate

    Case report 13 April 2019 Pages: 17 - 17

18. Aciclovir

    Case report 13 April 2019 Pages: 18 - 18

19. Acitretin

    Case report 13 April 2019 Pages: 19 - 19

20. Acitretin

    Case report 13 April 2019 Pages: 20 - 20

21. Adalimumab

    Case report 13 April 2019 Pages: 21 - 21

22. Adalimumab

    Case report 13 April 2019 Pages: 22 - 22

23. Adalimumab

    Case report 13 April 2019 Pages: 23 - 23

24. Adalimumab

    Case report 13 April 2019 Pages: 24 - 24

25. Adalimumab

    Case report 13 April 2019 Pages: 25 - 25

26. Adalimumab

    Case report 13 April 2019 Pages: 26 - 26

27. Adalimumab/etanercept

    Case report 13 April 2019 Pages: 27 - 27

28. Adalimumab/ferric carboxymaltose

    Case report 13 April 2019 Pages: 28 - 28

29. Afamelanotide misuse

    Case report 13 April 2019 Pages: 29 - 29

30. Aflibercept

    Case report 13 April 2019 Pages: 30 - 30

31. Afloqualone overdose

    Case report 13 April 2019 Pages: 31 - 31

32. Alemtuzumab

    Case report 13 April 2019 Pages: 32 - 32

33. Alemtuzumab

    Case report 13 April 2019 Pages: 33 - 33

34. Alemtuzumab

    Case report 13 April 2019 Pages: 34 - 34

35. Alemtuzumab

    Case report 13 April 2019 Pages: 35 - 35

36. Alemtuzumab

    Case report 13 April 2019 Pages: 36 - 36

37. Allopurinol

    Case report 13 April 2019 Pages: 37 - 37

38. Amantadine/chlorpromazine/risperidone

    Case report 13 April 2019 Pages: 38 - 38

39. Amiodarone

    Case report 13 April 2019 Pages: 39 - 39

40. Amiodarone

    Case report 13 April 2019 Pages: 40 - 40

41. Amiodarone

    Case report 13 April 2019 Pages: 41 - 41

42. Amisulpride

    Case report 13 April 2019 Pages: 42 - 42

43. Amoxicillin

    Case report 13 April 2019 Pages: 43 - 43

44. Amoxicillin

    Case report 13 April 2019 Pages: 44 - 44

45. Amphotericin B

    Case report 13 April 2019 Pages: 45 - 45

46. Amphotericin B/lamivudine/abacavir/raltegravir

    Case report 13 April 2019 Pages: 46 - 46

47. Amphotericin-B liposomal

    Case report 13 April 2019 Pages: 47 - 47

48. Ampicillin/sulbactam

    Case report 13 April 2019 Pages: 48 - 48

49. Anakinra

    Case report 13 April 2019 Pages: 49 - 49

50. Anastrozole

    Case report 13 April 2019 Pages: 50 - 50